Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
07/2003
07/03/2003WO2003054144A2 Human ras interacting protein
07/03/2003WO2003054141A2 Sperm-specific cation channel, catsper2, and uses therefor
07/03/2003WO2003054019A2 Therapeutic monoclonal anti-tirc7 antibodies for use in immune related and other diseases
07/03/2003WO2003054012A2 Leptin proteins
07/03/2003WO2003054005A2 Bone polypeptide-1
07/03/2003WO2003053476A1 Adeno-associated virus-mediated delivery of gdnf to skeletal muscles
07/03/2003WO2003053467A1 Drug for regenerating tissue and vessel and method therefor
07/03/2003WO2003053409A1 Liposome composition for delivery of nucleic acid
07/03/2003WO2003053365A2 Syn3 compositions and methods
07/03/2003WO2003053364A2 Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908
07/03/2003WO2003053360A2 Treatment of ebv and khsv infection and associated abnormal cellular proliferation
07/03/2003WO2003053341A2 Antisense modulation of ship-1 expression
07/03/2003WO2003025187A8 Improvement of gene expression in vectors
07/03/2003WO2003018788A3 Improved nitroreductase enzymes
07/03/2003WO2003016499A3 Combinatorial methods for inducing cancer cell death
07/03/2003WO2003013437A3 Compositions and methods for the prevention and treatment of huntington's disease
07/03/2003WO2003010284A3 Antisense modulation of c-reactive protein expression
07/03/2003WO2002098898A3 FLJs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
07/03/2003WO2002092014A3 Destruction of prions using vibriolysin or variants thereof
07/03/2003WO2002083080A9 Method of treating arthritis using lentiviral vectors in gene therapy
07/03/2003WO2002072616A3 Transfection complexes
07/03/2003WO2002070549A3 Chimeric polypeptides of serum albumin and uses related thereto
07/03/2003WO2002059604A3 Diagnosis and treatment of multiple sclerosis
07/03/2003WO2002042776A3 Compositions and methods relating to prostate specific genes and proteins
07/03/2003WO2002036761A3 Compositions and methods for the diagnosis of cancer
07/03/2003WO2002024733A3 Human polynucleotides and polypeptides encoded thereby
07/03/2003WO2002006317A3 Compositions and methods for the therapy and diagnosis of ovarian cancer
07/03/2003WO2001083750A9 Dendritic cell co-stimulator molecules
07/03/2003US20030126626 Rodent model which cultures human liver cells for regeneration of tissues, providing alternative to liver transplantation; side effect reduction; drug screening
07/03/2003US20030125615 Homing of autologous cells to a target zone in tissue using active therapeutics or substances
07/03/2003US20030125541 Replication competent hepatitus C virus and methods of use
07/03/2003US20030125537 Neovascularization; platelet derived growth factors; vascular permeability factors; wound healing agents; antitumor/antiproliferative agents; antisense agents; for treatment of intestinal malabsorption syndrome
07/03/2003US20030125536 Fusion proteins/antigen presenting cells for promoting expansion of lymphocytes; vaccines
07/03/2003US20030125533 Regulation of human sphingosine kinase-like protein
07/03/2003US20030125519 Ligand for the c-kit receptor and methods of use thereof
07/03/2003US20030125296 Insulin-responsive DNA binding protein-1 and methods to regulate insulin-responsive genes
07/03/2003US20030125295 Novel nucleic acid and amino acid sequences
07/03/2003US20030125294 Selective toxin expression in angiogenic endothelial cells
07/03/2003US20030125286 Transcriptional silencer protein NRF
07/03/2003US20030125281 Compositions and processes using siRNA, amphipathic compounds and polycations
07/03/2003US20030125278 Immunization of animals by topical applications of a salmonella-based vector
07/03/2003US20030125258 Bone polypeptide-1
07/03/2003US20030125253 Novel protein, process for producing the same and use therof
07/03/2003US20030125252 Administering to a vertebrate an effective osteogenesis stimulating amount of an RAR (retinoic acid receptor) antagonist to treat both metabolic or non-metabolic diseases; RAR antisense oligonucleotide
07/03/2003US20030125248 Novel bone mineralization proteins, DNA, vectors expression systems
07/03/2003US20030125247 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein
07/03/2003US20030125246 Respiratory system related polynucleotides and the polypeptides encoded by these polynucleotides known as respiratory system antigens useful for detecting cancer or cancer metastases of respiratory system tissues
07/03/2003US20030125242 Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells
07/03/2003US20030125235 Treating a condition comprising administering a pharmaceutically effective amount of an inhibitor of the Tec family of protein tyrosine kinases (PTKs). The condition is typically associated with cytokine production, for treatment
07/03/2003US20030125233 Use of urokinase inhibitors for the treatment and/or prevention of pulmonary hypertension and/or cardiac remodelling
07/03/2003US20030125232 Stabilized proteins with engineered disulfide bonds
07/03/2003US20030124723 Use of a nuclease inhibitor or interleukin-10 (IL-10) for the preparation of a therapeutic composition for improving transfection of a polynucleotide into a cell and compositions useful in gene therapy
07/03/2003US20030124721 Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof
07/03/2003US20030124718 Cytolytic T lymphocyte (CTL); viricides; particle acceleration apparatus
07/03/2003US20030124598 PGC-1beta, a novel PGC-1 homologue and uses therefor
07/03/2003US20030124596 Methods and compositions for treating hematological disorders using 232, 2059, 10630, 12848, 13875, 14395, 14618, 17692 or 58874
07/03/2003US20030124593 Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943
07/03/2003US20030124575 Dendritic cells; antigen presenting cells; g-protein coupled receptors; immunotherapy; antiinflammatory agents; antitumor agents; viricides; drug screening
07/03/2003US20030124558 Monitoring gestation in humans; in vitro fertilization and embryo transfer; progestins; immunohistochemistry
07/03/2003US20030124551 Agents implicated in endometriosis
07/03/2003US20030124534 Measuring expression of nucleotide sequences in cells
07/03/2003US20030124529 Pregnancy-associated plasma protein-A2 (PAPP-A2)
07/03/2003US20030124196 Pulsatile release compositions and methods for enhanced intestinal drug absorption
07/03/2003US20030124145 Avian polynucleotide vaccine formula
07/03/2003US20030124142 Immunomodulatory constructs and their uses
07/03/2003US20030124116 Antibodies binding to polypeptides encoded by the genes
07/03/2003US20030124107 PAK5-related compositions and methods
07/03/2003US20030124105 Programmed cell death genes and proteins
07/03/2003US20030124103 Tumor cells with increased immunogenicity and uses therefor
07/03/2003US20030124102 Differentiating adult pluripotent stem cells to produce myoblasts
07/03/2003US20030124100 Includes an endothelial specific enhancer element; especially modifications of the PPE promoter, which enhance its expression in response to hypoxia and angiogenesis.
07/03/2003US20030124097 Method to improve the safety of gene therapy
07/03/2003US20030124094 Increasing or maintaining the blood supply in the penis
07/03/2003US20030124092 IL-17 like molecules and uses thereoflike molecules and uses thereof
07/03/2003CA2486689A1 Therapeutic monoclonal anti-tirc7 antibodies for use in immune related and other diseases
07/03/2003CA2470999A1 Syn3 compositions and methods
07/03/2003CA2470938A1 Treatment of ebv and khsv infection and associated abnormal cellular proliferation
07/03/2003CA2470594A1 Leptin proteins
07/03/2003CA2470148A1 Inhibition of tristetraproline for protection of the heart from cardiac injuries
07/03/2003CA2470088A1 Identification of an amplified gene and target for drug intervention
07/03/2003CA2470063A1 Parmaceutical agents and methods for tissue and vascular regeneration
07/03/2003CA2469972A1 Bone polypeptide-1
07/03/2003CA2469941A1 Novel nucleic acids and polypeptides
07/03/2003CA2469658A1 Adeno-associated virus-mediated delivery of gdnf to skeletal muscles
07/03/2003CA2468882A1 A library of modified structural genes or capsid modified particles useful for the identification of viral clones with desired cell tropism
07/03/2003CA2468627A1 Liposome composition for delivery of nucleic acid
07/03/2003CA2462670A1 Sperm-specific cation channel, catsper2, and uses therefor
07/02/2003EP1323824A2 Use of human keratinocyte growth factor-2 for the preparation of pharmaceutical compositions
07/02/2003EP1323736A1 Chimeric human-type vascular endothelial cell growth factor
07/02/2003EP1323731A1 Novel peptides
07/02/2003EP1322778A2 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
07/02/2003EP1322774A2 Gene delivery vectors provided with a tissue tropism for dendritic cells
07/02/2003EP1322769A2 Protein phosphatases
07/02/2003EP1322768A2 Isolation of drosophila and human polynucleotides encoding par-1 kinase, polypeptides encoded by the polynucleotides and methods utilizing the polynucleotides and polypeptides
07/02/2003EP1322763A2 Listeria inocua , genome and applications
07/02/2003EP1322759A2 Potassium channel interactors and uses therefor
07/02/2003EP1322755A1 Human and mouse targeting peptides identified by phage display
07/02/2003EP1322658A1 Oligonucleotide modulation of her-1 expression
07/02/2003EP1322338A2 Compositions and methods of using capsid protein from flaviviruses and pestiviruses
07/02/2003EP1322337A2 Pei : dna vector formulations for in vitro and in vivo gene delivery
1 ... 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 ... 870